Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV. The USC team shows that a class of drugs called BET bromodomain inhibitors effectively targets primary effusion lymphoma, a type of cancer for which those drugs were not expected to be effective. Read more here.
Study mentioned: Tolani B, et al. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors. Oncogene. 2013 Jun 24. [Epub ahead of print] PMID: 23792448
No comments:
Post a Comment